AI-generated summary
The authors studied 41 elderly patients with coronary heart disease who received intravenous low-intensity red laser light (633 nm) together with medication. They report that changes in red blood cell number were seen by the third laser procedure, and that these changes correlated with treatment duration and were broader than those seen with medication alone. The authors suggest these blood changes may reflect treatment efficiency.
- Participants
- 41
- Who or what was studied
- Elderly patients with coronary heart disease
- Wavelengths
- 633 nm
- Limits stated in the abstract
- The abstract does not describe a control group, randomization, or statistical testing, and the study is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 633 nm
- Power density (irradiance)
- 124 mW/cm2
- Power
- 1 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.